FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1743581095> ?p ?o ?g. }

• W1743581095 endingPage "489" @default.
• W1743581095 startingPage "475" @default.
• W1743581095 abstract "Key points Periods of impaired oxygenation or acute hypoxia in the fetus can be common during labour and how the fetus withstands these challenges is of interest. During hypoxia, the fetus shunts blood flow away from peripheral and towards essential vascular beds: the so called brain-sparing effect. Part of the peripheral vasoconstriction is driven by reactive oxygen species (ROS) that inactivate nitric oxide (NO), thereby limiting its vasodilator action. Here, we investigate the source of ROS generation contributing to fetal peripheral vasoconstriction during hypoxia, and show that xanthine oxidase (XO) is fundamentally involved. Fetal exposure to the XO inhibitor allopurinol markedly diminished the peripheral vasoconstriction during hypoxia via NO-dependent mechanisms. The data increase our understanding of the physiological control of fetal cardiovascular function during stress. The findings are also of significant clinical relevance as allopurinol is being administered to pregnant women in clinical obstetric trials. Abstract Hypoxia is a common challenge to the fetus, promoting a physiological defence to redistribute blood flow towards the brain and away from peripheral circulations. During acute hypoxia, reactive oxygen species (ROS) interact with nitric oxide (NO) to provide an oxidant tone. This contributes to the mechanisms redistributing the fetal cardiac output, although the source of ROS is unknown. Here, we investigated whether ROS derived from xanthine oxidase (XO) contribute to the fetal peripheral vasoconstrictor response to hypoxia via interaction with NO-dependent mechanisms. Pregnant ewes and their fetuses were surgically prepared for long-term recording at 118 days of gestation (term approximately 145 days). After 5 days of recovery, mothers were infused i.v. for 30 min with either vehicle (n = 11), low dose (30 mg kg−1, n = 5) or high dose (150 mg kg−1, n = 9) allopurinol, or high dose allopurinol with fetal NO blockade (n = 6). Following allopurinol treatment, fetal hypoxia was induced by reducing maternal inspired O2 such that fetal basal decreased approximately by 50% for 30 min. Allopurinol inhibited the increase in fetal plasma uric acid and suppressed the fetal femoral vasoconstrictor, glycaemic and lactate acidaemic responses during hypoxia (all P < 0.05), effects that were restored to control levels with fetal NO blockade. The data provide evidence for the activation of fetal XO in vivo during hypoxia and for XO-derived ROS in contributing to the fetal peripheral vasoconstriction, part of the fetal defence to hypoxia. The data are of significance to the understanding of the physiological control of the fetal cardiovascular system during hypoxic stress. The findings are also of clinical relevance in the context of obstetric trials in which allopurinol is being administered to pregnant women when the fetus shows signs of hypoxic distress." @default.
• W1743581095 created "2016-06-24" @default.
• W1743581095 creator A5016922338 @default.
• W1743581095 creator A5026450012 @default.
• W1743581095 creator A5031123001 @default.
• W1743581095 creator A5035548522 @default.
• W1743581095 creator A5059683473 @default.
• W1743581095 creator A5060380241 @default.
• W1743581095 creator A5065050579 @default.
• W1743581095 creator A5090156858 @default.
• W1743581095 creator A5091120405 @default.
• W1743581095 date "2013-12-13" @default.
• W1743581095 modified "2023-09-25" @default.
• W1743581095 title "Xanthine oxidase and the fetal cardiovascular defence to hypoxia in late gestation ovine pregnancy" @default.
• W1743581095 cites W1546334556 @default.
• W1743581095 cites W1558216278 @default.
• W1743581095 cites W1823662212 @default.
• W1743581095 cites W1927006532 @default.
• W1743581095 cites W1943296211 @default.
• W1743581095 cites W1953423403 @default.
• W1743581095 cites W1993090386 @default.
• W1743581095 cites W2000609745 @default.
• W1743581095 cites W2020783425 @default.
• W1743581095 cites W2021597987 @default.
• W1743581095 cites W2022091875 @default.
• W1743581095 cites W2022451432 @default.
• W1743581095 cites W2024958336 @default.
• W1743581095 cites W2028067695 @default.
• W1743581095 cites W2028380826 @default.
• W1743581095 cites W2035125822 @default.
• W1743581095 cites W2041129027 @default.
• W1743581095 cites W2041424285 @default.
• W1743581095 cites W2053406948 @default.
• W1743581095 cites W2057893238 @default.
• W1743581095 cites W2074079870 @default.
• W1743581095 cites W2077726441 @default.
• W1743581095 cites W2078807139 @default.
• W1743581095 cites W2084284805 @default.
• W1743581095 cites W2086384373 @default.
• W1743581095 cites W2093454905 @default.
• W1743581095 cites W2106901294 @default.
• W1743581095 cites W2109521624 @default.
• W1743581095 cites W2109756862 @default.
• W1743581095 cites W2114256210 @default.
• W1743581095 cites W2118166125 @default.
• W1743581095 cites W2123732571 @default.
• W1743581095 cites W2126579708 @default.
• W1743581095 cites W2129194977 @default.
• W1743581095 cites W2130981336 @default.
• W1743581095 cites W2133126891 @default.
• W1743581095 cites W2141543212 @default.
• W1743581095 cites W2415190406 @default.
• W1743581095 doi "https://doi.org/10.1113/jphysiol.2013.264275" @default.
• W1743581095 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3930434" @default.
• W1743581095 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24247986" @default.
• W1743581095 hasPublicationYear "2013" @default.
• W1743581095 type Work @default.
• W1743581095 sameAs 1743581095 @default.
• W1743581095 citedByCount "33" @default.
• W1743581095 countsByYear W17435810952014 @default.
• W1743581095 countsByYear W17435810952015 @default.
• W1743581095 countsByYear W17435810952016 @default.
• W1743581095 countsByYear W17435810952017 @default.
• W1743581095 countsByYear W17435810952018 @default.
• W1743581095 countsByYear W17435810952019 @default.
• W1743581095 countsByYear W17435810952020 @default.
• W1743581095 countsByYear W17435810952021 @default.
• W1743581095 countsByYear W17435810952022 @default.
• W1743581095 countsByYear W17435810952023 @default.
• W1743581095 crossrefType "journal-article" @default.
• W1743581095 hasAuthorship W1743581095A5016922338 @default.
• W1743581095 hasAuthorship W1743581095A5026450012 @default.
• W1743581095 hasAuthorship W1743581095A5031123001 @default.
• W1743581095 hasAuthorship W1743581095A5035548522 @default.
• W1743581095 hasAuthorship W1743581095A5059683473 @default.
• W1743581095 hasAuthorship W1743581095A5060380241 @default.
• W1743581095 hasAuthorship W1743581095A5065050579 @default.
• W1743581095 hasAuthorship W1743581095A5090156858 @default.
• W1743581095 hasAuthorship W1743581095A5091120405 @default.
• W1743581095 hasBestOaLocation W17435810952 @default.
• W1743581095 hasConcept C126322002 @default.
• W1743581095 hasConcept C134018914 @default.
• W1743581095 hasConcept C172680121 @default.
• W1743581095 hasConcept C178790620 @default.
• W1743581095 hasConcept C181199279 @default.
• W1743581095 hasConcept C185592680 @default.
• W1743581095 hasConcept C2778102346 @default.
• W1743581095 hasConcept C2779234561 @default.
• W1743581095 hasConcept C2779961880 @default.
• W1743581095 hasConcept C2780261098 @default.
• W1743581095 hasConcept C29323129 @default.
• W1743581095 hasConcept C519581460 @default.
• W1743581095 hasConcept C540031477 @default.
• W1743581095 hasConcept C54355233 @default.
• W1743581095 hasConcept C55493867 @default.
• W1743581095 hasConcept C71924100 @default.
• W1743581095 hasConcept C7836513 @default.
• W1743581095 hasConcept C86803240 @default.

• next